Webinars

  • All
  • Healthcare Marketing
  • Privacy
  • DTC Marketing
  • Television
Swoop Swoop

How Pharma Marketers Can Navigate the Evolving Privacy Landscape

In this webinar, privacy experts share how brands can balance ethical data use with cutting-edge healthcare advertising strategies.
Swoop Swoop

How to Use Privacy-Safe Data to Optimize Healthcare Marketing

Kurt Robinson, SVP of Business Development for Swoop sat down with Jeanette Geer, Sr. Director of Healthcare Strategy at Spectrum Reach to discuss how to maximize marketing ROI while staying transparent and ethical, in a webinar for the American Marketing Association (AMA). The health systems-focused conversation covered how to leverage healthcare data effectively to optimize […]
Swoop Swoop

Why Marketers Must Make the Switch to Privacy-safe Real World Data for Targeting

Pharmaceutical and life sciences companies currently face forces of change upending and devaluing traditional advertising and promotion strategies. The resulting challenges are further exacerbated by recent privacy-driven platform announcements from Apple, Google and Facebook. Taken together, these macro trends and privacy changes have deprecated legacy targeting methodologies reliant on demographic and clickstream data. That’s why […]
Swoop Swoop

Transforming Connected TV: Unique Brands, Custom Audience Segments, Better Outcomes

With 93% of 18-49 U.S. households owning at least one internet-connected TV (CTV)*, medical marketers must transform from a “need to play” to a “need to optimize” mentality. During this educational webcast, attendees will learn from Swoop and Samsung how applying brand-exclusive custom audience segments to their CTV advertising can drive increased sales and reduce […]
Swoop Swoop

Developing a Privacy Conscience: Avoiding a Cambridge Analytica-Type Crisis (Or at Least Be Prepared for One)

The mission of the pharmaceutical industry is straightforward: Educate patients about disease states and the therapies that could effectively treat their conditions, as well as enable them to become active participants in their medical journey. But while the “what” pharmaceutical companies can say and the “how” they must say it is well regulated by the […]